Semaglutide and Early-Stage Metabolic Abnormalities in Individuals With Schizophrenia Spectrum Disorders
Anders Fink‐Jensen, Tina Vilsbøll, Marie Reeberg Sass, Maria Gefke et al.
Citations
3 citations
Journal
JAMA Psychiatry
Topics
Schizophrenia research and treatment
Field-Weighted Citation Impact (FWCI)
4.41
article
Semaglutide and Early-Stage Metabolic Abnormalities in Individuals With Schizophrenia Spectrum Disorders
Anders Fink‐Jensen, Tina Vilsbøll, Marie Reeberg Sass, Maria Gefke, Marchen Hviid, Peter Oturai, Alexandra Zamorski, Andreas Kjær, Andreas Jensen, Bolette Hartmann, C. von Schilling, Heidi Storgaard, Christoph Ulrich Correll, Line Jee Hartmann Rasmussen, Claus Thorn Ekstrøm, Christiane Schwarz, Jens Juul Holst, Maj Vinberg, Mette Kruse Klausen, Malte E. B. Giver
article en
3 citations
Abstract
No abstract available for this paper.
Publication Tag
JAMA PsychiatryVol. 83(2)
Institutions
University of Copenhagen (DK), Northwell Health (US), Steno Diabetes Centers (DK), Hofstra University (US), Novo Nordisk (Denmark) (DK), Mental Health Services (DK), Novo Nordisk Foundation (DK), Copenhagen University Hospital (DK), Rigshospitalet (DK), German Centre for Cardiovascular Research (DE), Early Intervention Foundation (GB), Zucker Hillside Hospital (US), Charité - Universitätsmedizin Berlin (DE)